J. Safra Sarasin Holding AG Raises Stock Holdings in Amrize Ltd $AMRZ

J. Safra Sarasin Holding AG raised its position in shares of Amrize Ltd (NYSE:AMRZFree Report) by 888.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 85,495 shares of the company’s stock after purchasing an additional 76,846 shares during the period. J. Safra Sarasin Holding AG’s holdings in Amrize were worth $4,117,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Global Retirement Partners LLC purchased a new stake in Amrize in the third quarter worth approximately $48,000. BNP Paribas Financial Markets purchased a new stake in Amrize in the second quarter worth about $59,000. Groupe la Francaise bought a new position in shares of Amrize during the second quarter valued at $60,000. Allianz SE purchased a new position in Amrize in the 2nd quarter worth approximately $80,000. Finally, Osaic Holdings Inc. bought a new position in Amrize during the second quarter valued at approximately $90,000.

Amrize Trading Down 0.5%

Shares of AMRZ opened at $54.19 on Wednesday. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $58.11. The business has a fifty day moving average price of $53.89. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The stock has a market cap of $29.97 billion and a price-to-earnings ratio of 29.45.

Amrize (NYSE:AMRZGet Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The company had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.49 billion. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year.

Insiders Place Their Bets

In other Amrize news, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction on Wednesday, November 19th. The shares were bought at an average price of $47.34 per share, with a total value of $94,680.00. Following the purchase, the director directly owned 4,958 shares in the company, valued at $234,711.72. The trade was a 67.61% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Jan Philipp Jenisch bought 55,000 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were bought at an average price of $52.64 per share, for a total transaction of $2,895,200.00. Following the completion of the acquisition, the chief executive officer owned 1,505,000 shares of the company’s stock, valued at approximately $79,223,200. This represents a 3.79% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders acquired 65,000 shares of company stock valued at $3,399,720.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on AMRZ shares. Oddo Bhf began coverage on shares of Amrize in a report on Monday, November 3rd. They set a “neutral” rating for the company. Barclays started coverage on Amrize in a research report on Tuesday, October 7th. They set an “equal weight” rating on the stock. Sanford C. Bernstein reiterated an “outperform” rating and set a $70.00 price objective on shares of Amrize in a research note on Thursday, December 18th. Wells Fargo & Company boosted their target price on shares of Amrize from $57.00 to $58.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Finally, Kepler Capital Markets upgraded shares of Amrize to a “strong-buy” rating in a research report on Tuesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $60.67.

Get Our Latest Analysis on AMRZ

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.